These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29084172)

  • 21. Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.
    Miller BR; Roitberg AE
    J Mol Graph Model; 2013 Sep; 45():84-97. PubMed ID: 24012872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Based Virtual Screening and In Vitro Evaluation of New
    Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
    Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
    Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosuppresive effects of ellagic acid and amelioration of the trypanosome-associated pathological features coupled with inhibitory effects on trypanosomal sialidase in vitro and in silico.
    Aminu R; Ibrahim MA; Rahman MA; Dash R; Umar IA
    Phytomedicine; 2017 Jul; 30():67-73. PubMed ID: 28545671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
    Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, México.
    Domínguez-Díaz LR; Eugenia Ochoa M; Soto-Castro D; Farfán N; Morales-Chamorro M; Yépez-Mulia L; Pérez-Campos E; Santillan R; Moreno-Rodríguez A
    Bioorg Med Chem; 2021 Oct; 48():116417. PubMed ID: 34571489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
    Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
    Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
    Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
    Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
    BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.
    Chacón-Vargas KF; Nogueda-Torres B; Sánchez-Torres LE; Suarez-Contreras E; Villalobos-Rocha JC; Torres-Martinez Y; Lara-Ramirez EE; Fiorani G; Krauth-Siegel RL; Bolognesi ML; Monge A; Rivera G
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
    Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
    Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanocidal Activity of Flavanone Derivatives.
    Maciel Diogo G; Andrade JS; Sales Junior PA; Maria Fonseca Murta S; Dos Santos VMR; Taylor JG
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
    Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
    PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.
    Sartor PA; Agusti R; Leguizamón MS; Campetella O; de Lederkremer RM
    Glycobiology; 2010 Aug; 20(8):982-90. PubMed ID: 20375068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
    Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
    Meinke S; Schroven A; Thiem J
    Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.